Guardian Pharmacy Services

GRDN

Market cap $2.48B

Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Guardian Pharmacy Services NYSE: GRDN reported what executives described as a solid first quarter of 2026, with management saying the company successfully navigated the initial implementation of the Inflation Reduction Act's new framework while maintaining its full-year revenue outlook and raising adjusted EBITDA guidance.

Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.

Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the first quarter ended March 31, 2026. The Company also updated its full-year guidance. First Quarter Financial Results Revenue of $336.6 million, up 2% year-over-year. Residents served ended the quarter at approximately 207,000, up 10% year-over-year. Net Income of $13.5 million, compared to $9.3 mill.

Guardian Pharmacy (GRDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) will be attending the Bank of America 2026 Healthcare Conference in Las Vegas on Wednesday, May 13, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 9:20 a.m. Pacific Daylight Time. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation accessible through Guardian Pharmacy Service's website at https://i.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release first quarter 2026 financial results after market close on Wednesday, May 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United Sta.

GRDN and ESCA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 10th, 2026.

ESCA, GRDN, TPST, ASTE and ECG have been added to the Zacks Rank #1 (Strong Buy) List on April 10th, 2026.